Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Journal of Cardiovascular Pharmacology|February 1, 1987
SQ 27,786 and SQ 28,853: two angiotensin converting enzyme inhibitors with potent diuretic activityJ M DeForrest, T L Waldron, J R Powell, et al.Clinical and Experimental Hypertension|January 1, 1980
Renal prostaglandins, renin release, and renal hemodynamic function in high renin statesJ O Davis, J M DeForrest, R H Freeman, et al.The American Journal of Physiology|June 1, 1979
Effects of the oral converting enzyme inhibitor SQ 14225 in experimental high output failureG M Williams, J O Davis, R H Freeman, et al.The American Journal of Physiology|April 1, 1981
Effects of indomethacin in dogs with acute and chronic renovascular hypertensionJ R Dietz, J O Davis, J M DeForrest, et al.Journal of Cardiovascular Pharmacology|July 1, 1990
Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE)J M DeForrest, T L Waldron, C Harvey, et al.Circulation Research|October 1, 1979
Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogsR H Freeman, J O Davis, G M Williams, et al.Drug Design and Delivery|September 1, 1987
Relationship between metabolism and pharmacologic activity of SQ 27,786, an angiotensin converting enzyme inhibitor with potent diuretic activityD W Everett, S M Singhvi, J M DeForrest, et al.Journal of Cardiovascular Pharmacology|July 1, 1990
Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal modelsJ M DeForrest, T L Waldron, C Harvey, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 1, 1989
Pharmacology of novel imidazole alcohol inhibitors of primate reninJ M DeForrest, T L Waldron, R S Oehl, et al.Journal of Cardiovascular Pharmacology|June 1, 1989
Preclinical pharmacology of zofenopril, an inhibitor of angiotensin I converting enzymeJ M DeForrest, T L Waldron, J Krapcho, et al.Pageof 4